Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2026-01-10 @ 3:07 PM
Study NCT ID:
NCT00684567
Status:
COMPLETED
Last Update Posted:
2017-06-07
First Post:
2008-05-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-09-27
Start Date Type:
ACTUAL
Primary Completion Date:
2007-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-22
First Submit QC Date:
None
Study First Post Date:
2008-05-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2008-10-31
Results First Submit QC Date:
None
Results First Post Date:
2009-03-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-15
Last Update Post Date:
2017-06-07
Last Update Post Date Type:
ACTUAL